Proton Therapy Systems Global Market Report 2024

The proton therapy systems market size has grown rapidly in recent years. It will grow from $1.17 billion in 2023 to $1.29 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The expansion witnessed in the historical period can be ascribed to several factors, including a rise in cancer incidence, heightened awareness among healthcare professionals, the expansion of healthcare infrastructure, increasing healthcare expenditure, and a growing demand for non-invasive treatment alternatives.

The proton therapy systems market size is expected to see rapid growth in the next few years. It will grow to $1.94 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The projected growth in the upcoming period is expected to be driven by several factors, notably the escalating burden of cancer, a surge in the adoption of proton therapy, heightened utilization in pediatric oncology cases, a rising preference for outpatient cancer treatment facilities, and an increasing emphasis on environmental sustainability. Key trends anticipated in the forecast period encompass the broader adoption of proton therapy, advancements in technology, integration of artificial intelligence, adoption of pencil beam scanning technology, and the implementation of hypo-fractionated proton therapy protocols.

The rising prevalence of cancer is expected to drive the expansion of the proton therapy systems market in the coming years. Cancer, characterized by abnormal cell growth capable of invading and spreading within the body, is increasingly prevalent due to factors like aging populations, lifestyle shifts, environmental influences, and improved detection and diagnostic methods. Proton therapy systems play a crucial role in cancer treatment by precisely targeting tumors with high radiation doses while minimizing harm to surrounding healthy tissue, potentially reducing side effects and enhancing treatment outcomes. For example, as reported by the American Cancer Society in January 2023, the number of cancer cases rose to 1,958,310 in 2023, marking a 3.16% increase from 1,898,160 in 2021. Consequently, the growing cancer prevalence is propelling the evolution of the proton therapy systems market.

Key players in the proton therapy systems market are concentrating on developing more compact and accessible systems, such as self-shielded proton accelerators, to tackle challenges related to facility space and installation complexity. Self-shielded proton accelerators enhance safety and streamline installation by minimizing external shielding structures typically needed for conventional proton therapy systems. For instance, in October 2022, Mevion Medical Systems unveiled its latest innovation, the MEVION S250-FIT proton therapy system, leveraging its self-shielded proton accelerator. This system, compatible with existing LINAC vaults, is the industry's first comprehensive proton treatment solution supporting rapid integration of technologies like ARC therapy, thus significantly lowering barriers to proton treatment adoption.

In April 2021, Siemens Healthineers, a German medical technology company, acquired Varian Medical Systems Inc. for an undisclosed sum. This acquisition aims to advance cancer treatment efforts and bolster Siemens Healthineers' position in healthcare. Varian Medical Systems Inc., a US-based medical technology firm, specializes in creating and manufacturing proton therapy and radiation devices and software for cancer treatment.

Major companies operating in the proton therapy systems market are Mitsubishi Electric Corporation, Toshiba Corporation, Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare, Sumitomo Heavy Industries Ltd., Hitachi High-Tech Corporation, Acibadem Healthcare Group, Elekta AB, Mirion Technologies, Ion Beam Applications SA, Sirtex Medical Limited, RaySearch Laboratories, Mevion Medical Systems, Sun Nuclear Corporation, ITEL Telecomunicazioni S.r.l, Advanced Oncotherapy plc, Provision Healthcare, Optivus Proton Therapy Inc., Provision Proton Partners International, Danfysik A/S, ProTom International, Best Cyclotron Systems, ACCEL Instruments GmbH, P-Cure Ltd.

North America was the largest region in the proton therapy systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proton therapy systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the proton therapy systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Proton therapy systems represent advanced medical equipment utilized in radiation therapy for cancer treatment. These systems are designed to deliver proton beams with pinpoint accuracy to tumor locations, thereby minimizing harm to adjacent healthy tissues. In comparison to traditional radiation therapy approaches, proton therapy offers superior treatment precision and decreased adverse effects.

The primary variants of proton therapy systems include those equipped with robotic positioning tables, integrated CT scanners, and integrated PET scanners. Proton therapy systems featuring robotic positioning tables incorporate advanced robotic technology to ensure precise patient positioning during treatment, facilitating the accurate delivery of proton beams to targeted areas. This not only enhances treatment efficacy but also improves patient comfort. These systems are available in single-room and multi-room configurations suitable for treating various types of cancer, such as brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, among others. End-users of proton therapy systems encompass hospitals, proton therapy centers, and other medical facilities.

The proton therapy systems market research report is one of a series of new reports that provides proton therapy systems market statistics, including proton therapy systems industry global market size, regional shares, competitors with a proton therapy systems market share, detailed proton therapy systems market segments, market trends and opportunities, and any further data you may need to thrive in the proton therapy systems industry. This proton therapy systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The proton therapy systems market consists of sales of cyclotron-based proton therapy systems, synchrotron-based proton therapy systems, and passive scattering systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.